BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18937712)

  • 1. Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome.
    Bideci A; Camurdan MO; Yeşilkaya E; Demirel F; Cinaz P
    J Obstet Gynaecol Res; 2008 Aug; 34(4):578-84. PubMed ID: 18937712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M; Orbtsova M; Terzieva D
    Akush Ginekol (Sofiia); 2008; 47(3):15-9. PubMed ID: 18756827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
    Mitkov M; Pehlivanov B; Orbetzova M
    Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of adiposity on leptin, LH and androgen levels in lean, overweight and obese PCOS patients.
    LaZovic G; Radivojevic U; Milicevic S; Spremovic S
    Int J Fertil Womens Med; 2007; 52(2-3):82-8. PubMed ID: 18320865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.
    Sağsöz N; Orbak Z; Noyan V; Yücel A; Uçar B; Yildiz L
    Fertil Steril; 2009 Aug; 92(2):660-6. PubMed ID: 18973889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome.
    Kale-Gurbuz T; Akhan SE; Bastu E; Telci A; Iyibozkurt AC; Topuz S
    J Pediatr Adolesc Gynecol; 2013 Feb; 26(1):27-30. PubMed ID: 23158749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome.
    Waśko R; Komarowska H; Warenik-Szymankiewicz A; Sowiński J
    Horm Metab Res; 2004 Mar; 36(3):170-3. PubMed ID: 15057670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum resistin levels in women with polycystic ovary syndrome.
    Panidis D; Koliakos G; Kourtis A; Farmakiotis D; Mouslech T; Rousso D
    Fertil Steril; 2004 Feb; 81(2):361-6. PubMed ID: 14967374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.
    Spritzer PM; Comim FV; Capp E; D'Avila A
    Horm Metab Res; 2005 Feb; 37(2):94-8. PubMed ID: 15778926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances.
    Olszanecka-Glinianowicz M; Madej P; Nylec M; Owczarek A; Szanecki W; Skałba P; Chudek J
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):238-42. PubMed ID: 23199261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum resistin level is a predictor of ovarian response in in vitro fertilisation cycle.
    Chen YC; Tsai EM; Chen HS; Liu YH; Lee CH; Chou FH; Chen IJ; Chen SY; Jong SB; Chan TF
    Acta Obstet Gynecol Scand; 2007; 86(8):963-7. PubMed ID: 17653882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
    Banaszewska B; Spaczyński RZ; Pelesz M; Pawelczyk L
    Rocz Akad Med Bialymst; 2003; 48():131-4. PubMed ID: 14737959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality.
    Baldani DP; Skrgatic L; Kasum M; Zlopasa G; Kralik Oguic S; Herman M
    Gynecol Endocrinol; 2019 May; 35(5):401-405. PubMed ID: 30623695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].
    Hu WH; Qiao J; Li MZ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):721-4. PubMed ID: 17565837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.